CareClinics unique hunger tracking features allow you to: Rate your hunger levels throughout the day, helping you identify when true hunger (versus emotional eating) occurs Track satiety signals how quickly you feel full and how long that fullness lasts Document food aversions or preference changes , which commonly develop during GLP-1 treatment Monitor portion sizes as your appetite decreases, ensuring youre still getting adequate nutrition This detailed appetite tracking helps you work with your bodys changing signals rather than against them, making your weight management journey more intuitive and sustainable
Location: Plainsboro, New JerseyWarning Letter Date: September 9, 2025FDA Department Issuing Warning: Center for Drug Evaluation and Research (CDER)Type of Warning: False & Misleading Claims/Misbranded DrugsSubject of Violation: An Oprah Special: Shame, Blame, and the Weight Loss Revolution, regarding Wegovy (semaglutide) injection, for subcutaneous use, Ozempic (semaglutide) injection, for subcutaneous use, and Victoza (liraglutide) injection, for subcutaneous use.FDA Warning: In the program, which aired on television in 2024 and until recently was available continuously on the ABC website and through various streaming services, Novo Nordisk promoted Wegovy, Ozempic, and Victoza in a manner that failed to present the serious risks of these drug products in a truthful and nonmisleading manner
As expected, we found that MB07811 treatment not only reduced the body weight, fat weight, liver weight without changing food intake, but also lowered the blood glucose levels in HFD-fed mice (Fig
The compound can be administered systemically and still provide benefit, but for a targeted structural injury like a rotator cuff tear, proximity matters
